News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Approves Teva Pharmaceutical Industries Limited (TEVA)'s Generic Version of Roche (RHHBY)'s Xeloda



9/17/2013 7:17:17 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The U.S. Food and Drug Administration said it approved Teva Pharmaceutical Industries Ltd's generic version of Roche Holding AG's cancer drug Xeloda. Teva Pharmaceuticals USA, a unit of the generic drugmaker, will market 150 and 500 milligram doses of the oral drug, named capecitabine. The drug, like Xeloda, will have a boxed warning about an increased risk of bleeding in patients who are on blood thinners .

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at Bloomberg
Read at Globes Online
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES